Creating and Restoring Equal Access to Equivalent Samples Act of 2018
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in senate (Apr 27, 2017)
Creating and Restoring Equal Access To Equivalent Samples Act of 2017 or the CREATES Act of 2017
This bill permits the developer of a drug or biological product to bring a civil action against the license holder of an approved drug or biological product if the holder has declined to make available sufficient quantities of the approved drug or product for the developer's testing.
What just happenedJun 21, 2018
Placed on Senate Legislative Calendar under General Orders. Calendar No. 482.
Who’s behind it
- Reported to SenateJun 21, 2018
- Introduced in SenateApr 27, 2017
- Jun 21, 2018Calendars
Placed on Senate Legislative Calendar under General Orders. Calendar No. 482.
- Jun 21, 2018Committee
Committee on the Judiciary. Reported by Senator Grassley with an amendment in the nature of a substitute. Without written report.
Judiciary Committee - Jun 21, 2018Committee14000
Committee on the Judiciary. Reported by Senator Grassley with an amendment in the nature of a substitute. Without written report.
Judiciary Committee - Jun 14, 2018Committee
Committee on the Judiciary. Ordered to be reported with an amendment in the nature of a substitute favorably.
Judiciary Committee - Apr 27, 2017IntroReferral
Read twice and referred to the Committee on the Judiciary. (Sponsor introductory remarks on measure: CR S2619)
Judiciary Committee - Apr 27, 2017IntroReferral10000
Introduced in Senate